arrow
N

Naohiko Nakanishi

Kyoto Prefectural University of Medicine
H指数:18
被引数:911

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral Anticoagulants

接受直接口服抗凝剂治疗的癌症相关静脉血栓栓塞症的出血风险评估模型

2026-06-160
OAAI
Number of thrombosed venous segments and clinical outcomes in cancer-associated isolated distal deep vein thrombosis: insights from the ONCO DVT Study

癌症相关性孤立性下肢深静脉血栓中血栓静脉段数量与临床结局:来自ONCO DVT研究的启示

2026-01-010
PRE
Immunosuppressive Therapy for Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases: Insights from Japanese Registry

结缔组织疾病相关肺动脉高压的免疫抑制治疗:来自日本登记研究的见解

2025-10-090
PRE
The influence of metastasis on clinical outcomes in patients with cancer-associated isolated distal deep vein thrombosis: A pre-specified subgroup analysis from the ONCO DVT study

肿瘤相关孤立性下肢深静脉血栓患者中,转移对临床结局的影响:ONCO DVT研究的事先指定亚组分析

2025-09-030
PREAI
Impact of thrombocytopenia in patients with cancer-associated isolated distal deep vein thrombosis treated with edoxaban for 12 months versus 3 months: Insights from the ONCO DVT study

癌症相关孤立性远端深静脉血栓患者中血小板减少症的影响:比较使用依度沙班治疗12个月与3个月的效果——来自ONCO DVT研究的见解

2025-08-060
PRE
Clinical outcomes of cancer-associated isolated distal deep vein thrombosis: a comparison between asymptomatic and symptomatic thrombosis-findings from the ONCO DVT Study
2025-02-010
OAAI
Utility of the modified Ottawa score for identification of more preferable candidates of extended anticoagulation therapy in cancer-associated isolated distal deep vein thrombosis: insight from the ONCO DVT Study
2024-12-010
PRE
Edoxaban for 12 vs. 3 months in cancer-associated isolated distal deep vein thrombosis according to different doses: insights from the ONCO DVT study
2024-04-220
OAAI
The impact of renal function on clinical outcomes of patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT study
2024-03-012
PRE
Adult-onset idiopathic peripheral pulmonary artery stenosis
2023-12-073
OAAI
Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial
2023-11-2116
PRE